Search & Analyze

Jubilant Pharmova Ltd.

926.80−15.60 (−1.66%)

BSE · 30 Oct, 4:01 PM

: ₹14,728.73 Cr
: 41.83
: 3,580
: ₹952.45 - ₹920.00
: ₹1,183.90 - ₹783.75

Jubilant Pharmova Ltd. (JUBLPHARMA) share price closed at ₹926.80 on the BSE on Friday, October 30, 2026, down by 1.66% from its of ₹942.40. In that session JUBLPHARMA reached a of 952.45 and of 920.00. The for the session was 931.35. The stands at 962.56 and is at 945.02. Looking at , the stock ended the session in Downtrend.

Stock Overview

₹949.65

₹942.40

₹931.35

₹962.56

Price 3.72% below

₹945.02

Price 1.93% below

Key Fundamentals

: 14,728.73 Cr₹14.73 Thousand Crore
: 22.11
: 41.83
: 2.07
: 447.64
: 1,292.10 Cr₹1.29 Thousand Crore
: 0.54 %
Sector
Industry: Pharmaceuticals & Drugs
: 5.97
: 0.46

Industry Comparison

Ratio	Company	Sector
	41.83	44.77
	0.46	0.20
	2.07	4.61
	1.62	1.81
	0.54 %	0.11 %
Operating Margin	14.41 %	19.15 %

Sector figures are the median of 154 listed Healthcare companies.

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,778.25	38.91	4,26,661.74	0.90	1,995.07	-36.16%	16,198.71	11.88%	19.11
DIVI'S LAB. DIVISLAB	9,715.00	88.17	2,57,902.73	0.31	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,635.15	83.01	1,76,306.21	0.82	534.00	-9.64%	4,979.00	50.79%	19.27
LAURUSLABS LAURUSLABS	2,392.00	96.46	1,29,242.68	0.08	436.19	124.27%	2,206.37	33.44%	18.20
ZYDUSLIFE ZYDUSLIFE	1,244.00	27.50	1,24,089.48	0.08	990.20	-34.90%	8,017.00	21.96%	21.39
DR.REDDY'S DRREDDY	1,350.20	40.25	1,12,698.53	0.59	913.20	-31.69%	8,697.80	-1.48%	13.75
CIPLA LTD. CIPLA	1,380.00	38.48	1,11,488.55	0.94	851.51	-37.08%	7,403.93	-2.44%	16.00
Jubilant Pharmova Ltd. JUBLPHARMA	926.80	41.83	14,728.73	0.54	56.40	-44.98%	2,229.40	17.29%	8.69

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	1,758.60	1,731.70	1,752.30	1,821.70	1,928.80	1,900.70	1,966.40	2,122.50	2,290.00	2,229.40
Expenses	1,487.20	1,480.20	1,462.90	1,534.30	1,583.40	1,611.10	1,625.00	1,833.00	1,950.70	1,981.40
	271.40	251.50	289.40	287.40	345.40	289.60	341.40	289.50	339.30	248.00
	15.43%	14.52%	16.52%	15.78%	17.91%	15.24%	17.36%	13.64%	14.82%	11.12%
	-154.50	409.90	7.50	-9.70	8.60	12.00	4.00	-19.20	10.00	19.90
Interest	73.00	71.00	61.00	55.60	52.70	49.00	50.20	56.10	56.50	54.20
	101.00	90.70	91.40	91.30	95.20	98.10	104.80	120.70	116.80	127.30
	-53.70	499.70	144.40	130.50	206.00	154.40	190.30	93.40	176.00	86.40
	-15.08%	3.58%	29.02%	22.84%	26.55%	33.61%	36.99%	40.26%	32.22%	34.72%
	-58.60	482.10	102.80	100.90	153.60	102.90	120.30	55.90	119.40	56.50
	-3.71	30.51	6.51	6.39	9.72	6.51	7.61	3.54	7.56	3.58

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	6,130.16	6,281.70	6,702.90	7,644.30	8,745.50
	6,130.16	6,281.70	6,702.90	7,234.50	8,279.60
EXPENDITURE :
Increase/Decrease in Stock	-62.32	-40.70	78.20	34.60	10.90
Raw Material Consumed	1,550.33	1,918.60	2,062.50	2,282.40	2,633.40
Power & Fuel Cost	134.30	166.70	148.90	154.30	155.50
Employee Cost	2,043.39	2,166.00	2,216.00	2,267.90	2,700.60
Other Manufacturing Expenses	562.32	581.10	523.20	546.00	650.00
General and Administration Expenses	432.34	464.10	475.00	495.20	586.00
Selling and Distribution Expenses	209.71	161.60	214.30	205.80	205.70
Miscellaneous Expenses	103.77	88.10	84.00	74.60	77.70
	4,973.83	5,505.50	5,802.10	6,060.80	7,019.80
Operating Profit (Excl OI)	1,156.33	776.20	900.80	1,173.70	1,259.80
	11.29	38.30	68.70	56.80	66.00
	1,167.62	814.50	969.50	1,230.50	1,325.80
Interest	145.49	188.20	272.30	240.30	211.80
PBDT	1,022.13	626.30	697.20	990.20	1,114.00
	381.70	554.00	381.90	368.60	440.40
Profit Before Taxation & Exceptional Items	640.43	72.30	315.30	621.60	673.60
Exceptional Income / Expenses		-56.80	-168.90	359.50	-59.20
	630.45	27.80	170.50	980.60	614.10
Provision for Tax	217.43	92.70	97.80	144.30	216.60
	413.02	-64.90	72.70	836.30	397.50
Extra items			0.00	0.00	0.00
Minority Interest	0.92	3.90	4.40	3.10	1.00
Consolidated Net Profit	413.94	-61.00	77.10	839.40	398.50
Profit Balance B/F	4,317.71	4,685.00	4,536.80	4,539.70	5,301.80
Appropriations	4,731.65	4,624.00	4,613.90	5,379.10	5,700.30
Equity Dividend %	500.00%	500.00%	500.00%	500.00%	500.00%
	26.01	-3.84	4.88	53.13	25.22
Adjusted EPS	26.01	-3.84	4.88	53.13	25.22

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	15.92	15.90	15.80	15.80	15.80
Share Warrants & Outstandings	3.66	6.20	14.50	14.90	19.20
Total Reserves	5,298.98	5,377.20	5,403.60	6,224.30	7,057.80
Reserve excluding Revaluation Reserve	5,298.98	5,377.20	5,403.60	6,224.30	7,057.80
Revaluation reserve	0.00	0.00
	5,318.56	5,399.30	5,433.90	6,255.00	7,092.80
Minority Interest	-2.16	-7.50	-12.80	-16.30	2.80
Secured Loans	200.94	265.10	299.30	237.20	378.00
Unsecured Loans	2,263.30	2,845.30	2,867.80	1,913.10	2,593.70
Deferred Tax Assets / Liabilities	141.69	78.70	-21.90	-85.20	-6.40
Other Long Term Liabilities	219.99	483.70	760.40	1,911.60	2,506.30
Long Term Provisions	95.67	92.20	100.10	119.10	159.50
Total Non-Current Liabilities	2,921.60	3,765.00	4,005.70	4,095.80	5,631.10
Trade Payables	567.74	821.30	856.30	1,004.80	1,234.10
Other Current Liabilities	838.52	552.10	732.80	844.00	1,027.90
Short Term Borrowings	64.00	258.30	196.50	219.00	162.50
Short Term Provisions	121.35	140.70	103.40	96.80	114.40
Total Current Liabilities	1,591.60	1,772.40	1,889.00	2,164.60	2,538.90
Total Liabilities	9,829.60	10,929.20	11,315.80	12,499.10	15,265.60
Gross Block	6,758.89	7,368.00	7,868.90	7,822.90	10,167.20
Less: Accumulated Depreciation	1,888.28	2,184.70	2,777.70	2,647.00	3,201.60
	4,870.61	5,183.30	5,091.20	5,175.90	6,965.60
	291.83	773.30	1,252.30	2,714.70	2,961.50
Non Current Investments	238.60	256.40	42.20	43.50	61.40
Long Term Investment	238.60	256.40	42.20	43.50	61.40
Long Term Loans & Advances	117.65	161.50	191.90	54.10	66.00
Other Non Current Assets	3.98	4.10	11.30	18.30	22.90
Total Non-Current Assets	6,320.40	7,166.80	7,439.70	8,921.80	11,156.30
Inventories	1,254.87	1,380.50	1,289.60	1,129.20	1,231.50
Sundry Debtors	927.99	961.20	915.90	891.50	1,069.60
Cash and Bank	984.24	1,014.30	956.80	1,088.80	1,267.60
Other Current Assets	110.93	135.10	241.90	154.00	219.60
Short Term Loans and Advances	231.17	271.30	228.00	246.30	321.00
Total Current Assets	3,509.19	3,762.40	3,632.20	3,509.80	4,109.30
Net Current Assets (Including Current Investments)	1,917.59	1,990.00	1,743.20	1,345.20	1,570.40
Total Assets	9,829.60	10,929.20	11,315.80	12,499.10	15,265.60
	420.31	402.30	456.20	368.40	419.40
Total Debt	2,927.62	3,410.10	3,414.10	2,436.90	3,219.50
	333.91	339.19	343.00	394.94	447.70
Adjusted Book Value	333.91	339.19	343.00	394.94	447.70

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	630.45	27.80	170.50	980.60	614.10
Adjustment	579.47	782.90	755.40	218.10	682.70
Changes In working Capital	-178.29	54.30	253.10	111.80	139.40
Cash Flow after changes in Working Capital	1,031.63	865.00	1,179.00	1,310.50	1,436.20
Cash Flow from Operating Activities	837.54	660.70	971.30	1,072.10	1,226.80
Cash Flow from Investing Activities	-380.37	-544.40	-607.90	487.70	-1,260.00
Cash Flow from Financing Activitie	-32.60	-156.70	-432.50	-1,452.70	94.90
Net Cash Inflow / Outflow	424.57	-40.40	-69.10	107.10	61.70
Opening Cash & Cash Equivalents	501.96	983.80	1,013.90	956.40	1,088.30
Effect of Foreign Exchange Fluctuations	57.29	70.50	11.60	24.80	117.10
Closing Cash & Cash Equivalent	983.82	1,013.90	956.40	1,088.30	1,267.10

Ratios

Valuation

41.83

2.07

12.91

1.72

22.11

447.64

Profitability

5.97

8.69

2.86

14.41

4.55

Leverage & Liquidity

0.46

1.62

3.90

Returns

0.54

0.63

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26	Sep '26
	50.68	50.68	50.68	50.68	47.68	47.68	47.68	47.68	47.68	47.68
	23.56	23.60	23.93	24.26	26.92	27.09	27.18	27.52	28.27	28.40
	25.77	25.73	25.39	25.06	25.40	25.24	25.14	24.80	24.05	23.92
	49.32	49.32	49.32	49.32	52.32	52.32	52.32	52.32	52.32	52.32
No. of Shareholders	81,992	89,456	1,02,442	96,526	99,673	93,336	90,133	86,347	82,703	82,602

Mutual Funds Invested(35)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 23 active funds hold 9.24% in Jubilant Pharmova Ltd., contributing to ₹1.51K Cr of holdings

Fund				As of
ID Bandhan Small Cap Fund - Growth - Direct PlanSmall cap Fund	501.33	1.40	48,72,987	Sep '26
QU Quant Small Cap Fund - Growth - Direct PlanSmall cap Fund	303.21	0.85	29,47,185	Sep '26
KO Kotak Multi Cap Fund - Growth - Direct PlanMulti Cap Fund	188.15	0.62	18,28,846	Sep '26
ID Bandhan Focused Fund - Growth - Direct PlanEquity - Focused Fund	129.83	6.22	12,61,984	Sep '26
AB Abakkus Flexi Cap Fund - Growth - Direct PlanFlexi Cap Fund	63.16	0.81	6,13,923	Sep '26
AB Aditya Birla Sun Life Small Cap Fund - Growth - Direct PlanSmall cap Fund	51.51	0.84	5,00,687	Sep '26
HD HDFC Manufacturing Fund - Growth - Direct PlanEquity - Thematic Fund - Other	51.44	0.50	5,00,000	Sep '26
AB Abakkus Small Cap Fund - Growth - Direct PlanSmall cap Fund	48.27	1.49	4,69,188	Sep '26
HD HDFC Pharma and Healthcare Fund - Growth - Direct PlanPharma & Health Care	32.67	0.93	3,17,568	Sep '26
KO Kotak Special Opportunities Fund - Growth - Direct PlanEquity - Thematic Fund - Other	29.40	1.53	2,85,765	Sep '26

Corporate Actions

Showing: All

Date	Type	Details
2026-10-07	Board Meeting	Inter alia, to consider and approve raising of funds through the issuance of NonConvertible Debentures (NCDs) and/or such other securities as may be permitted under applicable laws, and to approve seeking shareholders' approval, as may be required in this regard.
2026-08-05	Board Meeting	Quarterly Results
2026-08-03	AGM

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcarePharmaceuticals & Drugs

Jubilant Pharmova Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

11 members across the board and senior leadership

Naresh Kapoor

Company Secretary & Compliance Officer

—

Shyam S Bhartia

Chairman

₹24.00 L

Mar '26

Hari S Bhartia

Co-Chairman

₹21.00 L

Mar '26

Priyavrat Bhartia

Managing Director

₹7.50 Cr

Mar '26

Arjun Shanker Bhartia

Joint Managing Director

₹7.50 Cr

Mar '26

Sushil Kumar Roongta